Li Dean Y's Form 4 filing
Merck & Co., Inc. (MRK) · filed Feb 10, 2026
- Accession no.
- 0000310158-26-000050
- Filed
- Feb 10, 2026
- Trade date
- Feb 10, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $1.20M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Li Dean YCIK 0001837016 | Officer (Executive VP & President, MRL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | Common Stock | SSaleDisposed | −10,235 | $117.52 | −$1,202,817.2 | 92,035.05 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.